CYCLOBENZAPRINE HYDROCHLORIDE TABLETS

The Defense Logistics Agency awarded a delivery order to Cardinal Health, Inc. for the supply of 2 blister packs of Cyclobenzaprine Hydrochloride Tablets, with a total contract value of $7.30, under the base contract SPE2DX-25-D-8022. The order was issued on July 16, 2026, and requires delivery by that date FOB destination to Electric Boat Corporation in North Stonington, Connecticut, with inspection and acceptance occurring at the delivery point. The awardee is certified as a Small Disadvantaged Women-Owned Small Business and provides its CAGE code 00E55. The product is identified by NSN 6505010628010 and must be labeled with the correct National Drug Code and CAGE code. Shipment must be sent via the fastest traceable method, prohibiting parcel post, and must include accurate container tracking identifiers. Packaging and marking requirements mandate alignment with the order’s identification numbers, but specific MIL-STD references, barcoding standards, or preservation methods are not detailed. Payment will be processed by DEF FIN AND ACCOUNTING SVC through remittance to Columbus, Ohio, using code SL4701, and invoicing is handled electronically. The contracting officer is Lisa Quinn, with administrative support provided by Michelle Pampel. No options, indefinite quantities, or performance periods beyond the single delivery date are included. The acquisition falls under NAICS code 424210, and while no FAR clauses are explicitly listed, the order incorporates terms from the underlying base contract. No specific technical standards like USP or ASTM are cited, though pharmaceutical integrity is implied. No COR or COTR is designated, and no special requirements such as security clearances or OCI provisions are referenced in available documentation.